Session

Overview: The optimal indication and implementation of brachytherapy as a boost after external radiotherapy for locally advanced prostate cancer is often a subject of controversy. The aim of the symposium is to present and discuss the current issues about the indication of brachytherapy as a boost from different perspectives - from the point of view of medical physics, radiation biology and radiation oncologists, in particular the current quality of evidence of brachytherapy as a boost with regard to efficacy and side effects. In addition, the current evidence for patient selection and the possible use of artificial intelligence in prostate brachytherapy will be presented.